Personalizing Antithrombotic Therapy in COVID-19: Role of Thromboelastography and Thromboelastometry.

Chaudhary, Rahul; Kreutz, Rolf P; Bliden, Kevin P; Tantry, Udaya S; Gurbel, Paul A

Chaudhary, Rahul; Kreutz, Rolf P; Bliden, Kevin P; Tantry, Udaya S; Gurbel, Paul A.

Chaudhary R; Division of Hospital Internal Medicine, Mayo Clinic, Rochester, Minnesota, United States.
Kreutz RP; Sinai Center of Thrombosis Research, Sinai Hospital of Baltimore, Baltimore, Maryland, United States.
Bliden KP; Department of Internal Medicine, Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, Indiana, United States.
Tantry US; Sinai Center of Thrombosis Research, Sinai Hospital of Baltimore, Baltimore, Maryland, United States.
Gurbel PA; Sinai Center of Thrombosis Research, Sinai Hospital of Baltimore, Baltimore, Maryland, United States.

Thromb Haemost ; 120(11): 1594-1596, 2020 11.

Article in English | MEDLINE | ID: covidwho-653554

Subject(s)

COVID-19; Thrombophilia; Fibrinolytic Agents/adverse effects; Hemostasis; Humans; Intensive Care Units; Pandemics; Patients; Role; SARS-CoV-2; Thrombelastography

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Thrombophilia / COVID-19 Limits: Humans Language: English Journal: Thromb Haemost Year: 2020 Document Type: Article Affiliation country: S-0040-1714217

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google